naion semaglutide news Ozempic linked to increased risk of eye condition naion

Although rare, GLP-1s tied to higher risk for eye complications

21.31

★★★★☆4.8 (126)

And here it is, the long-awaited top story from 2024. Thanks for following our countdown to No. 1! Since the 2017 FDA approval of semaglutide to treat type 2 diabetes and obesity,

23.77

★★★★★4.9 (98)

A new clinical trial supported by the National Institutes of Health (NIH) found that a medication commonly used for weight loss, such as semaglutide, may also help reduce heavy drinking in individuals

25.29

★★★★★5.0 (157)

Semaglutide use linked with increased risk for NAION in patients with diabetes

24.40

★★★★★4.7 (84)

Semaglutide Once Again Linked to NAION in Largest Study to Date

28.18

★★★★★4.9 (203)

Can Semaglutides (Ozempic) Cause Blindness? A recent study hints at a potential link between semaglutide use and an increased risk of a serious eye condition called non-arteritic anterior ischemic optic neuropathy (NAION )

26.63

★★★★★5.0 (176)

Semaglutide doubles risk for nonarteritic anterior ischemic optic neuropathy

22.97

★★★★★4.8 (132)